RESTORE TRIAL: Study of the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)
Clinical trial NCT07009860 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07009860
- Sponsor
- Altimmune, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-16
- Primary completion
- 2027-09-30
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.